supported by the China National Science Fund Committee (No. 30872393);Postgraduate Innovation Foundation of Simcere Pharmaceutical Group(No. CX10B-004XS)
Cancer cell vaccine-based immunotherapy has received increasing interest in many clinical trials involving patients with breast cancer. Combining with appropriate adjuvants can enhance the weak immunogenic properties ...